JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2176
PUT
SAP
SAP
$243B
| $8.87M | ﹤0.01% |
+97,800
| New | +$9.77M |
2022 Q2
0 quarters
|
|
2177
CALL
Intuitive Surgical
ISRG
$142B
| $8.87M | ﹤0.01% |
44,200
+4,800
| +12% | +$1.13M |
2017 Q2
20 quarters
|
|
2178
Federated Hermes
FHI
$4.19B
| $8.84M | ﹤0.01% |
278,056
-105,001
| -27% | -$3.33M |
2013 Q2
36 quarters
|
|
2179
New York Times
NYT
$10.3B
| $8.82M | ﹤0.01% |
316,163
+14,141
| +5% | +$511K |
2016 Q4
22 quarters
|
|
2180
Embecta
EMBC
$328M
| $8.82M | ﹤0.01% |
+348,333
| New | +$10M |
2022 Q2
0 quarters
|
|
2181
iShares MSCI ACWI ex US ETF
ACWX
$15.9B
| $8.81M | ﹤0.01% |
195,799
+9,763
| +5% | +$473K |
2013 Q2
36 quarters
|
|
2182
PJT Partners
PJT
$3.59B
| $8.8M | ﹤0.01% |
125,285
+107,122
| +590% | +$7.45M |
2015 Q4
26 quarters
|
|
|
SCS
2183
DELISTED
Steelcase
SCS
| $8.79M | ﹤0.01% |
819,161
-27,467
| -3% | -$318K |
2013 Q2
36 quarters
|
|
2184
Zumiez
ZUMZ
$205M
| $8.78M | ﹤0.01% |
337,589
-456
| -0.1% | -$15.3K |
2016 Q4
22 quarters
|
|
2185
Haemonetics
HAE
$4.75B
| $8.77M | ﹤0.01% |
134,625
-454
| -0.3% | -$26.9K |
2015 Q4
26 quarters
|
|
|
JIB
2186
DELISTED
Janus Henderson Sustainable & Impact Core Bond ETF
JIB
| $8.77M | ﹤0.01% |
200,000
| – | – |
2021 Q3
3 quarters
|
|
2187
REX American Resources
REX
$1.45B
| $8.75M | ﹤0.01% |
619,404
+252,090
| +69% | +$3.71M |
2013 Q2
36 quarters
|
|
|
NVMI
2188
Nova
NVMI
$12.3B
| $8.72M | ﹤0.01% |
98,530
-67,249
| -41% | -$6.7M |
2018 Q3
15 quarters
|
|
|
CIXX
2189
DELISTED
CI Financial Corp.
CIXX
| $8.7M | ﹤0.01% |
818,956
-268,572
| -25% | -$3.4M |
2020 Q4
6 quarters
|
|
2190
PUT
Abbott
ABT
$167B
| $8.69M | ﹤0.01% |
80,000
-47,400
| -37% | -$5.38M |
2017 Q3
19 quarters
|
|
2191
Vanguard Russell 1000 Value ETF
VONV
$21.4B
| $8.68M | ﹤0.01% |
136,519
-3,073
| -2% | -$211K |
2019 Q1
13 quarters
|
|
2192
Belden
BDC
$4.23B
| $8.68M | ﹤0.01% |
162,839
+19,492
| +14% | +$1.04M |
2013 Q2
36 quarters
|
|
2193
Urban Edge Properties
UE
$2.47B
| $8.67M | ﹤0.01% |
569,817
-45,088
| -7% | -$806K |
2015 Q3
27 quarters
|
|
2194
PUT
Ares Capital
ARCC
$13.8B
| $8.63M | ﹤0.01% |
481,200
+332,900
| +224% | +$6.56M |
2022 Q1
1 quarter
|
|
2195
National Bank Holdings
NBHC
$1.74B
| $8.61M | ﹤0.01% |
225,116
+68,599
| +44% | +$2.67M |
2013 Q2
36 quarters
|
|
2196
CALL
HCA Healthcare
HCA
$91.7B
| $8.61M | ﹤0.01% |
51,200
+47,400
| +1,247% | +$10.2M |
2021 Q2
4 quarters
|
|
2197
Tandem Diabetes Care
TNDM
$1.15B
| $8.6M | ﹤0.01% |
145,224
+11,827
| +9% | +$971K |
2018 Q1
17 quarters
|
|
2198
CALL
BioMarin Pharmaceuticals
BMRN
$11.3B
| $8.59M | ﹤0.01% |
+103,700
| New | +$8.26M |
2022 Q2
0 quarters
|
|
|
IBTX
2199
DELISTED
Independent Bank Group, Inc.
IBTX
| $8.59M | ﹤0.01% |
126,515
+4,792
| +4% | +$334K |
2017 Q4
18 quarters
|
|
|
CNVY
2200
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $8.59M | ﹤0.01% |
825,972
+819,345
| +12,364% | +$5.08M |
2021 Q2
4 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.